Uncategorized
Regeneron total revenues increased by 22% to $726 million in Q3
Regeneron reported total revenues of $726 million for the third quarter of 2014, compared with $597 million 1 year ago, according to a company press release.Third-quarter net product sales were $449 million, compared with $367 million in the third quarter of 2013. In the U.S., Eylea (aflibercept) net product sales were $445 million in the third quarter of 2014, compared with $363 million in last year’s third quarter.